DTYMK and hepatocellular carcinoma: These cells or appropriate controls were then subcutaneously implanted into BALB/c nude mice, and tumor growth was monitored over time, revealing that suppressing DTYMK expression markedly inhibited the ability of these HCC tumors to grow in vivo (Figure 2E).